Source:http://linkedlifedata.com/resource/lhgdn/association:17447
| Subject | Predicate | Object | Context |
|---|---|---|---|
| lhgdn:association:17447 | lhgdn:found_in | pubmed-article:16126463 | lld:lhgdn |
| lhgdn:association:17447 | lhgdn:geneRifSource | BMPs influence the formation of the osteolytic prostate cancer metastases, and treatment modalities that inhibit BMP activity may limit the progression of the lytic component of prostate cancer metastases. | lld:lhgdn |
| lhgdn:association:17447 | lhgdn:mesh_code | D009362 | lld:lhgdn |
| lhgdn:association:17447 | lhgdn:associationIdType | http://bio2rdf.org/euadr:Al... | lld:lhgdn |
| lhgdn:association:17447 | lhgdn:umls_code | umls-concept:C0027627 | lld:mappings |
| entrez-gene:650 | lhgdn:associationId | lhgdn:association:17447 | lld:lhgdn |